As technology advances there is a growing array of MedTech solutions – wearables, voice-activated devices, telehealth, etc. – to better support patients in their daily lives. However, MedTech research ...

AstraZeneca (AZ) and Merck’s – known as MSD outside the US and Canada – Lynparza (olaparib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a ...

New national surveillance data announced at the UK Health Security Agency (UKHSA) annual conference has demonstrated an increase in antibiotic resistant infections and associated deaths in England.

The US Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee have completed its meeting for CRISPR Therapeutics and Vertex Pharmaceuticals’ exagamglogene ...

The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

By Niamh ManganFive years ago, the revolution in remote working that has taken place would have been impossible to imagine. When 2020 hit, we had no choice but to change. The technology was in place, ...

CMS deputy administrator and director of the CMS Innovation Center, Liz Fowler, said the models would “test strategies to make it easier for Medicare patients to afford and access needed prescriptions ...

Researchers at the Institute of Cancer Research (ICR) in London have discovered new inhibitors that block the action of a protein involved in driving several cancer types. According to the team, with ...

The World Health Organization (WHO) has unveiled plans to establish a tuberculosis (TB) vaccine accelerator council to speed up the licensing and use of effective novel vaccines against the disease.

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...

Gilead and EVOQ Therapeutics (EVOQ) have entered into a collaboration and licensing agreement aimed at advancing immunotherapies for the treatment of rheumatoid arthritis (RA) and lupus. Under the ...